Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Emmaus Life Sciences, Inc. (EMMA) had Return on Equity of 11.78% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$12.45M |
|
$-7.49M |
|
$0.86M |
|
$11.60M |
|
$12.22M |
|
$0.23M |
|
$-7.71M |
|
$-7.48M |
|
$-6.95M |
|
$-7.49M |
|
$-7.49M |
|
$-7.49M |
|
$-6.96M |
|
$0.23M |
|
$0.83M |
|
64.04M |
|
64.04M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$7.75M |
|
$0.11M |
|
$13.69M |
|
$21.44M |
|
$69.07M |
|
$2.27M |
|
$15.97M |
|
$85.04M |
|
$-63.61M |
|
$-63.61M |
|
$-63.61M |
|
70.19M |
|
| Cash Flow Statement Financials | |
$-0.01M |
|
$2.17M |
|
$-1.43M |
|
$1.39M |
|
$2.13M |
|
$0.74M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.11 |
|
-- |
|
-- |
|
-0.04 |
|
-0.48 |
|
93.12% |
|
1.85% |
|
1.85% |
|
6.67% |
|
-60.09% |
|
-60.16% |
|
$-0.01M |
|
-- |
|
-- |
|
-- |
|
0.58 |
|
0.55 |
|
4.44 |
|
82.19 |
|
|
Return on Equity |
11.78% |
11.78% |
|
-34.95% |
|
12.21% |
|
$-0.91 |
|
$-0.00 |
|
$-0.00 |
|